# MICAFUNGIN SODIUM
> **ANDA211713** · Abbreviated New Drug Application (Generic) · Sponsor: XELLIA PHARMS APS · Approved 2021-06-02
## Drug
- **FDA Application Number:** ANDA211713
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MICAFUNGIN SODIUM
- **Generic name:** Micafungin Sodium
- **Active ingredients:** MICAFUNGIN SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** XELLIA PHARMS APS
- **First approval:** 2021-06-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211713)
---
*AI Analytics · CC0 1.0*